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The prion protein (PrP) binds Cu2+ in its N-terminal octarepeat domain. This
unusual domain is comprised of four or more tandem repeats of the
fundamental sequence PHGGGWGQ. Previous work from our laboratories
demonstrates that at full copper occupancy, each HGGGW segment binds a
single Cu2+. However, several recent studies suggest that low copper
occupancy favors different coordination modes, possibly involving imidazoles
from histidines in adjacent octapeptide segments. This is investigated here
using a combination of X-band EPR, S-band EPR, and ESEEM, along with a
library of modified peptides designed to favor different coordination
interactions. At pH 7.4, three distinct coordination modes are identified. Each
mode is fully characterized to reveal a series of copper-dependent octarepeat
domain structures. Multiple His coordination is clearly identified at low copper
stoichiometry. In addition, EPR detected copper−copper interactions at full
occupancy suggest that the octarepeat domain partially collapses, perhaps
stabilizing this specific binding mode and facilitating cooperative copper
uptake. This work provides the first complete characterization of all dominant
copper coordination modes at pH 7.4.

Introduction
Conversion of the prion protein (PrP) from its normal cellular
form (PrPC) to the scrapie form (PrPSc) is responsible for a class of
infectious, neurodegenerative diseases referred to as the transmissible
spongiform encephalopathies (TSEs).1,2 The TSEs include mad cow
disease (BSE), scrapie in goats and sheep, chronic wasting disease
(CWD) in deer and elk, and, in humans, kuru and Creutzfeldt−Jakob
disease (CJD). In contrast to other known infectious diseases resulting
from viruses or bacteria, the transmissible agent requires only protein
in the form of β-sheet rich PrPSc.3
PrPC is found in a wide range of tissues. Within the central
nervous system, it is localized primarily at presynaptic membranes,4,5
attached through a glycophosphatidylinositol (GPI) anchor.6 The
normal function of PrPC in healthy tissues is not known. However, since
the landmark work of Brown et al. in 1997,7 accumulating evidence
links PrPC function to its ability to bind Cu2+. To refine possible
physiological roles for PrPC, there are intensive efforts to clearly define
the Cu2+ coordination environment.8-25 Mature PrPC is a 209 amino acid
(after removal of the signal peptide) glycoprotein with a folded Cterminus and an unstructured (in the absence of Cu2+) N-terminus.26 A
variety of experiments using peptides and recombinant PrP (rPrP) find
that most copper ions bind in the N-terminal octarepeat domain
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residue sequence PHGGGWGQ (residues 60−91 in the four octarepeat
hamster sequence).13,14,17,20 Recent experiments point to an additional
binding site involving either His9611,20 or His111,16 although there is
current disagreement as to its exact location.16 In the fully occupied
octarepeat domain, each octarepeat segment binds a single Cu2+ ion.
As demonstrated by our laboratories using EPR and X-ray
crystallography, copper forms a pentacoordinate complex involving the
specific residues HGGGW.8,10 Equatorial coordination involves the His
imidazole, deprotonated amides from the following two Gly residues
and the amide carbonyl from the second glycine. An oxygen from a
water molecule coordinates axially and bridges to the NH of the Trp
indole.
Although the detailed features of fully copper-occupied PrPC are
now well established, little is known about the copper coordination
geometry, or the structure of the N-terminal domain, at intermediate
Cu2+ occupancy. Moreover, no experiments thus far have elucidated
any possible molecular interactions among the distinct copper sites in
the fully occupied state. These issues are vital for understanding how
PrPC responds to localized changes in Cu2+ concentrations that are
known to take place in the central nervous system, particularly at
synapses.5 For example, PrPC is constitutively cycled through
endocytosis. Addition of Cu2+ rapidly stimulates this process, resulting
in significant PrPC internalization.27 Mutant PrPC lacking the N-terminal
octarepeat domain is less efficiently endocytosed in the presence of
copper. It has been proposed that elevation of the Cu2+ concentration
introduces a structural change in PrPC that increases its association
with membrane components targeted for compartmentalization to the
endosome.27
PrPC is also implicated in protecting neurons against coppermediated oxidative stress. Because of its intrinsic redox activity
involving the oxidation states Cu2+ and Cu+, high concentrations of
uncomplexed or weakly complexed copper contribute to the production
of reactive oxygen species, which are toxic to cells. A growing number
of experiments indeed show that wild-type neurons in culture are more
resistant to copper toxicity than are cells lacking PrP.5,28,29
Correspondingly, comparison of tissues between normal mice and PrP
knockouts reveals extensive oxidative damage in the latter.30
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Together, these findings suggest a copper buffering role for PrP where
the protein protects cells from uncomplexed Cu2+. Mechanistic support
for this type of function comes from several copper binding
experiments that reveal micromolar dissociation constants, well
matched to extracellular Cu2+ levels,23,31,32 with significant positive
binding cooperativity,23,32 suggesting that PrPC is able to alter structure
from a state of low copper affinity to a multiply occupied state of high
affinity, over a narrow copper concentration range.
At full occupancy, each octarepeat histidine coordinates to single
Cu , as described above. However, at intermediate occupancy, a
single Cu2+ may be coordinated by two or more His imidazoles.15,33,34
Although a detailed mechanism has not yet been proposed, significant
changes in octarepeat organization may ultimately explain the
molecular basis for the proposed binding cooperativity.33 Alternatively,
distinct binding modes as a function of copper occupancy may point to
a copper sensing role for PrPC, or even a protein that carries out
several different functions depending on the extracellular Cu2+
concentration.
2+

Studies from our laboratories, using multi-frequency and pulsed
EPR, along with designed libraries of isotopically labeled peptides, have
defined the coordination mode in the fully occupied octarepeat domain
as described above.8,10,17 Additional studies with folded, recombinant
PrPC demonstrate that this defined coordination mode is preserved in
the full-length protein.11 In the course of our studies with copper
complexes of the octarepeat domain, corresponding to PrP(57−91),8
and with rPrP,11 we identified EPR spectra reflecting a superposition
consistent with two or more bound species. Only the dominant binding
mode at full occupancy has thus far been characterized. In light of the
numerous structural and physiological issues above, we investigate
here the structural features over a range of Cu2+ concentrations. EPR
spectra clearly identify three distinct binding modes at pH 7.4. Using a
combination of EPR techniques, along with a variety of octarepeat
domain constructs and isotopic labeling, we characterize the
coordination features of each mode. Moreover, we reinvestigated
spectra obtained at high copper occupancy and find evidence for close
copper−copper contacts consistent with a packing interaction in the
copper loaded N-terminal octarepeat domain.
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Materials and Methods
Peptide Synthesis and Purification. All peptides containing
common amino acids were prepared using fluorenylmethoxycarbonyl
(Fmoc) methods, as described previously.8,10 Peptides were acetylated
at the N-terminus and amidated at the C-terminus. N-Methylated
glycine was introduced by the coupling of bromoacetic acid to the
preceding glycine using 1,3-diisopropylcarbodiimide (DIC)/N,Ndiisopropylethylamine (DIEA) in dichloromethane for 30 min, followed
by reaction with methylamine in tetrahydrofuran (THF) for another 30
min.35 The next amino acid was coupled in the conventional fashion.
To methylate the amide nitrogen of histidine, the Fmoc group was
removed and the resulting free N-terminal amine was protected using
o-nitrobenzenesulfonyl chloride (3 equiv) and collidine (3 equiv) for 30
min.36 The methyl group was then added by coupling with 3 equiv of
methyl-4-nitrobenzenesulfonate in the presence of 3 equiv of
1,3,4,6,7,8-hexahydro-1-methyl-2H-pyrimido[1,2-a]-pyrimidine
(MTBD) for30 min. The N-terminal nitrogen was then deprotected
using 1,8-diazabicyclo[5.4.0]-undec-7-ene (DBU) (3 equiv) and βmercaptoethanol (3 equiv) for 30 min. All peptides were acetylated
prior to cleavage and purified by reverse-phase HPLC.
Electron Paramagnetic Resonance (EPR) Spectroscopy. All
samples were prepared with degassed buffer containing 25 mM Nethylmorpholine (NEM) buffer and 20% glycerol (v/v) where the
glycerol served as a cryoprotectant.8 X-band spectra (frequency =
9.43 GHz, microwave power in the range 0.6−5.0 mW, modulation
amplitude in the range 5.0−15 G) were acquired using a Bruker
EleXsys 500 spectrometer and a TE102 or SHQ (Bruker) cavity equipped
with a variable temperature controller. 63Cu (99.62%, Cambridge
Isotope Laboratories) was used to avoid inhomogeneous broadening of
the S-band EPR lines that would otherwise be present with the mixture
of naturally occurring isotopes. S-band spectra (3.5 GHz) were
acquired in D2O solution at 133 K using a loop gap resonator as part of
a specially designed spectrometer housed at the Biomedical ESR
Center at the Medical College of Wisconsin. Three-pulse ESEEM
measurements were obtained at 4.2 K on an X-band pulsed-EPR
spectrometer located at the Albert Einstein College of Medicine. The
instrument, cavity, and resonator were constructed in-house and have
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been previously described.37,38 Data were obtained at g⊥, the point of
greatest spectral intensity (3280 G at 9.47 GHz). Data processing to
attain frequency domain spectra for three-pulse ESEEM was carried
out using software described in previous work.39 Echo detected spectra
were obtained at 6 K with a repetition rate of 33 Hz and 30 averages
per magnetic field point. Additional experimental parameters for all
pulsed experiments are provided in figure legends.
EPR spectra were simulated using previously reported
procedures40 using the program XSophe (Bruker Biospin)41 and
employing the spin Hamiltonians

and

for one- and two-copper simulations, respectively. J contains both
isotropic and anisotropic coupling terms between the two S = 1/2 spins.
Signals were simulated assuming equivalent g and A for the two
individual Cu2+ ions. The appearance of the g ≈ 2 region of the spectra
due to spin-coupled Cu2+ ions was largely dictated by g⊥, and while the
simulations were sensitive to the inter-Cu(II) distance, they did not
provide good estimates for g∥ and A∥ in this case. In contrast, the half
field simulations provided good estimates for g∥ and A∥, in addition to
the inter-Cu2+ distance. An isotropic exchange coupling was assumed
with JS1S2 > βgHS (an arbitrary value of 35 cm-1 was used).
Structure Calculations. Calculations for the various binding
modes used the CYANA torsional dyanamics program.42 A histidine
residue with copper bound was added to the CYANA library. The
copper ion was placed 2.0 Å from the Histidine Nδ atom consistent
with the HGGGW crystal structure. Each calculation maintained fixed
peptide bond distances and angles and used upper limit restraints and
torsion angle dynamics to produce a low energy structure. In each
case, 50 structures were calculated, and the lowest energy conformer
is shown (Figure 8). The following upper and lower limit restraint files
were used for the various components. Component 1 maintained the
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structure of the HGGGW as it appears in the crystal structure, and
additionally included a fixed copper−copper distance of 4.0 Å between
two of the centers. Component 2 used a fixed 2.0 Å distance between
each copper atom and the histidine amide nitrogen and Nδ, and a 2.4
Å distance to the Nε of the preceding histidine. Component 3 has a
single copper coordinated to three histidines with a fixed distance of
2.0 Å between the Cu2+ and the histidine Nε atoms.

Results
Cu2+ binds primarily within the octarepeat domain, residues
60−91 in hamster PrP (SHaPrP), consisting of four tandem repeats of
the fundamental eight-residue sequence PHGGGWGQ (Table 1).11,17
There is an additional binding site at His96,11,16 and perhaps at
His111,16 although there is currently disagreement about the precise
location of this nonoctarepeat copper. It has been noted previously
that EPR spectra reflect a change in coordination geometry as a
function of relative Cu2+/PrP concentrations, suggesting alternate
binding modes at low copper levels.8 This is investigated here with a
series of EPR spectra obtained as a function of copper concentration at
pH 7.4. The soluble octarepeat domain construct, PrP(23−28, 57−91),
was used to yield high signal/noise spectra without interference from
the nonoctarepeat binding sites.8 Spectra obtained from 0.25 to 2.0
equiv of Cu2+ (added to a solution containing 200 μM peptide), in
increments of 0.25 equiv, are shown in Figure 1. At 2.0 equiv and
above, the spectra are dominated by a signal previously referred to as
component 1.8,11 (A more extensive set of spectra up to 6.0 equiv of
Cu2+ is in the Supporting Information.) However, at low occupancy,
two additional EPR spectra emerge, and this is clearly seen in the
expansion of the low field spectral range showing the mI = −3/2 and mI
= −1/2 hyperfine lines. The additional spectrum observed between
approximately 1.0 and 2.0 equiv is referred to as component 2.8 At 1.0
equiv and below, a single spectrum, referred to as component 3,
dominates. This process is reversible and reveals a coexistence among
three distinct copper bound species. Magnetic parameters, g∥ and A∥,
determined from the parallel region of the three spectral components
are summarized in Table 2. Below we characterize each of the distinct
binding modes.
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Figure 1 X-band EPR spectra of PrP(23−28, 57−91) (200 μM) as a function of Cu2+
concentration, represented in equivalents. Three distinct species are observed, as can
be clearly seen in the inset showing an expansion of the mI = −3/2 and mI = −1/2
hyperfine lines. The grids at the top identify the four hyperfine lines arising from
coupling to the 63Cu (I = 3/2) nucleus for each spectral species. Spectra were obtained
at approximately 77 K and νo = 9.44 GHz.

Table 1. Peptide Sequencesa
component
1

2

3

KKRPKPWGQ(PHGGGWGQ)4 PrP(23−28, 57−91)

X

X

X

(PHGGGWGQ)3

X

X

X

HGGGWGQPHGGGW

X

X

PHGGGWGQ

X

HGGGW

X

KKRPKPWGQ(PHGXGWGQ)4

X

HGXGWGQPHGXGW

X

HGXGW

X

HXGGW

X

X

HGGGWGQPYGGGW

X

YGGGWGQPHGGGW

X

HGGGWGQPYGGGWGQPHGGGW
a X = sarcosine (N-methylglycine).

X
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Table 2.
A∥
g∥

MHz

Gauss

coordinationa

center charge
0
0a

component 1

2.24

492

157

3N 1O

component 2

2.27

530

167

2N 2O

component 3
3N 1O or 4N
2.25
576
183
using Peisach−Blumberg correlations.43

0 or +1a

a Assigned

Component 1 Coordination − High Cu2+ Occupancy. The
local Cu2+ coordination environment of component 1 was previously
characterized using EPR, including X-band, S-band, and ESEEM, as
well as X-ray crystallography.10 Coordination is localized within the
octarepeat subsegment HGGGW and involves the His imidazole and
deprotonated amide nitrogens from the following two Gly residues in
the equatorial plane, as well as an axial water that hydrogen bonds to
the NH of the Trp indole.10,17
Table 1 shows a series of PrP-derived peptide constructs along
with spectral components observed from titration studies, such as
those carried out in Figure 1. (Additional EPR spectra vs added Cu2+
are given in the Supporting Information.) As observed in our previous
studies, component 1 is found in the minimal binding sequence
HGGGW, as well as in all longer constructs including the full, fouroctarepeat domain. Moreover, quantitative titration studies showed
that each octarepeat binds a single equivalent of Cu2+.8
Although the local coordination in component 1 binding is fully
elucidated, the relative spatial positioning among the Cu2+ containing
HGGGW segments is unknown. However, contacts between copper
centers, as revealed by dipolar interactions, may be informative, and
this is investigated in Figure 2. The EPR spectrum obtained from the
octarepeat segment PHGGGWGQ is nearly equivalent to that obtained
from the fully occupied octarepeat domain PrP(23−28, 57−91).8 Both
spectra are dominated by component 1 binding, although the
octarepeat domain shows residual component 2 binding as well.
However, PrP(23−28, 57−91) reveals additional features at
approximately 3100 G (where it adds to the mI = 1/2 copper hyperfine
line) and 3475 G, as indicated by the arrows. These features are
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suggestive of a strongly coupled dipolar spectrum superimposed on
the uncoupled component 1 spectrum.40

Figure 2 X-band EPR spectra showing the approximate equivalence of fully occupied
PrP(23−28, 57−91) and PHGGGWGQ. The spectrum for PrP(23−28, 57−91) also
reveals features associated with dipolar coupling (arrows). The echo detected
spectrum of PrP(23−28, 57−91), obtained with a two pulse sequence (τ = 140 ns, νo
= 9.63 GHz, T = 6 K), selects for slowly relaxing species and lacks the dipolar
features, thus confirming a spectral superposition. The inset shows the half field signal
(νo = 9.63 GHz) obtained from PrP(23−28, 57−91) with 2.0 equiv of Cu2+. The
simulation (dashed line) for the g ≈ 2 spectrum was generated with a superposition of
a mononuclear species (80%) and a coupled species (20%) using the parameters g∥ =
2.227, g⊥ = 2.052, and A∥ = 162 G and g∥ = 2.176, g⊥ = 2.058, and A∥ = 165 G,
respectively, and a distance of 6.0 Å. The simulation of the half field signal (dashed
line) used g∥ = 2.174, g⊥ = 2.058, and A∥ = 162 G and a distance of 4.9 Å. In addition,
the g tensors for the Cu(II) ions were assumed to be collinear with an intercopper
vector at a 10° ± 5° angle to the z direction.

To evaluate whether the spectrum of fully occupied PrP(23−28,
57−91) with 2 or more equiv of Cu2+ is indeed a superposition of two
types of copper centers (noninteracting and dipolar/exchange
interacting), an echo detected (ED) spectrum was obtained. Coupling
between paramagnetic species via exchange and/or dipolar
interactions can lead to increases in relaxation rates44,45 and fielddependent pulse turning angles46 relative to the isolated species.
These differences can be exploited to separate the contributions of
species using pulsed EPR spectra,47 including echo detected spectra.4850
The ED spectrum is shown as a derivative in Figure 2 and gives
component 1 characteristics but without the added features assigned
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to the strongly dipolar coupled spectrum. This finding supports the
assignment of a superposition spectrum for PrP(23−28, 57−91).
Strong dipolar coupling should be accompanied by a half field
transition arising from a ΔMs = 2 transition.51,52 Investigation of
PrP(23−28, 57−91) in the vicinity of 1600 G indeed reveals a half field
signal that is not observed in the monomeric octarepeats as shown in
Figure 2.
To extract distance information, we performed simulations of
both the full field g ≈ 2 spectrum and the half field spectrum. The g ≈
2 spectrum was treated as a superposition, and the best fit suggested
that the coupled spectrum comprised approximately 20% of the total
signal with a distance between copper centers of 6.0 Å. The half field
signal reveals a multiplet structure arising from the copper hyperfine
interactions. Interestingly, at high copper occupancy, the half field
signal persists but the muliplet lines are no longer resolved (data not
shown). This is presumably due to interactions among more than two
copper centers, thus giving rise to a superposition of multiplets with
different hyperfine patterns. Two equivalents of copper gave the
cleanest half field signal, and simulations were performed on this
spectrum, as shown in Figure 2. Treating this spectrum as arising from
a single coupled species, the best fit gave a distance of 4.9 Å. As a
second approach for evaluating distances between copper centers, we
examined the relative integrated intensities of the half field and g ≈ 2
spectra. It is well established that this ratio scales as 1/r6.51,52
Estimating that the coupled spectrum at g ≈ 2 comprises
approximately 20% of the total signal intensity, the distance
determined by this approach gives approximately 3.5 Å. There may be
a distribution of distances between copper centers. The 1/r6
dependence of the half field signal intensity, as compared to the 1/r3
dependence for the g ≈ 2 dipolar coupling, gives a bias toward shorter
distances,52 and, hence, the value of 3.5 Å should be considered a
lower bound.
These findings suggest a previously unseen packing interaction
between copper binding segments in the component 1 coordination
mode. The possible consequences of this interaction will be considered
in the Discussion.
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Component 2 Coordination − Intermediate Cu2+
Occupancy. Table 1 shows that component 2 binding is observed only
in PrP constructs containing two or more octarepeat segments.
Interestingly, the shortest PrP segment containing two HGGGW binding
units, HGGGWGQPHGGGW, exhibits component 1 and component 2
spectra, but not component 3 (Supporting Information). Unfortunately,
under all conditions studied, this construct gives a superposition of the
two binding modes, thus confounding attempts to clearly characterize
the molecular features exclusive to component 2.
Given that two sequential octarepeats provide a minimal model
for component 2 binding, we sought an approach for blocking the
formation of component 1. Component 1 binding arises from
coordination of the His imidazole and deprotonated amide nitrogens
from the two Gly residues immediately following the His (vide supra;
also see Figure 6). Thus, N-methylation of either of these Gly residues
to give the sarcosyl derivative of glycine will directly interfere with
component 1 formation. This is investigated in Figure 3. Indeed, the
construct HGXGWGQPHGXGW, where X = Sar (N-methyl glycine),
when loaded with Cu2+ yields a spectrum with g∥ and A∥, and overall
spectral shape equivalent to component 2. Moreover, the spectrum
represents a homogeneous coordination environment with no
indication of component 1 or other species. Blocking component 1
binding in an analogue of the full octarepeat domain using the
construct KKRPKPWGQ(PHGXGWGQ)4 gives a superposition of
component 2 and component 3 (Supporting Information).
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Figure 3 X-band EPR spectra of PrP constructs containing N-methylated glycine
(sarcosine, X) at specific positions to block component 1 binding. Methylation of the
first or second glycine results in pure component 2 binding.

Analysis of g∥ and A∥ of copper bound to HGXGWGQPHGXGW, as
interpreted through the Peisach−Blumberg correlations,43 suggests
coordination by approximately two nitrogens and two oxygens (2N
2O), for an uncharged complex, or 3N 1O for a complex with a positive
charge. To determine whether component 2 requires the two tandem
octarepeats, the peptides HXGGW and HGXGW, derived from single
repeats, were each independently investigated. Figure 3 shows that
each of these peptides gives component 2 binding indistinguishable
from that obtained from the two repeat construct HGXGWGQPHGXGW,
although HXGGW does exhibit a weak signal at 2780 G that may
represent an additional species. Methylation at the third glycine, which
does not coordinate Cu2+ in component 1,10 gives an EPR spectrum
equivalent to unmodified HGGGW, as expected (Figure 3).
Three-pulse electron spin−echo envelope modulation (ESEEM)
was performed to evaluate nearby, noncoordinated nitrogen atoms.
With imidazole coordination, the remote nitrogen is ESEEM active and,
indeed, serves as a diagnostic for equatorial binding of the His side
chain.53 In addition, for component 1, the nitrogen of the third Gly in
the HGGGW sequence is also observable because it is rigidly held
approximately 4 Å from the Cu2+ center by coordination of the amide
carbonyl between the second and third Gly residues (see Figure 6).10
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ESEEM spectra for HGXGWGQPHGXGW and HGXGW are shown in
Figure 4. The spectra are approximately equivalent and give three lowfrequency lines at 0.65, 0.85, and 1.50 MHz arising from transitions of
a coupled 14N in an electron spin manifold under near exact
cancellation conditions, which is typical of imidazole coordination.53,54
The broad signal near 4.0 MHz arises from the ΔmI = 2 transition from
the other electron spin manifold. The ESEEM spectra suggest a Cu2+
center coordinated by a single equatorial imidazole. There is no
evidence of either combination lines or an enhanced ΔmI = 2 transition
as might be seen as arising from multiple imidazole coordination.55
Moreover, direct simulations in the time domain (not shown) are fully
consistent with a single equatorial imidazole.

Figure 4 Three-pulse ESEEM spectra of constructs that exhibit component 2 binding
showing single imidazole coordination. Spectra were obtained at 4.2 K from the g⊥
region of the spectrum with τ = 150 ns.

Analysis of hyperfine multiplets arising from nitrogen couplings
allows for direct mapping of the copper coordination environment. Sband EPR is ideal for resolving such couplings56 and was used
previously to identify nitrogens bound to copper in the octarepeat.8,10
The benefit of S-band EPR arises from a partial cancellation of g-strain
and A-strain induced inhomogeneous broadening specifically for the
63
Cu mI = −1/2 hyperfine line.56 HGXGW is chosen as a representative
construct because it is the minimal peptide that gives a pure
component 2 spectrum. The full S-band spectrum is shown in Figure 5
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and indeed reveals superhyperfine couplings in the mI = −1/2 line. The
mI = −1/2 line is further expanded in Figure 5B and reveals a five-line
multiplet consistent with coordination by two nitrogens. To evaluate
whether either of the Gly residues following the His coordinates to the
copper center, 15N-Gly analogues at the nonmethylated positons of of
HGXGW were examined. A difference in multiplet structure upon
change of nuclear spin (I = 1 for 14N and I = 1/2 for 15N) is directly
observable if the modified nitrogen is equatorially bound to Cu2+.10
Figure 5 shows that there is no resolvable difference in the hyperfine
pattern of the mI = −1/2 line, demonstrating that neither of the labeled
Gly residues are directly bound to the Cu2+ center.

Figure 5 S-band EPR of HGXGW that favors component 2 binding. (A) Shows the full
scan, (B) expansion of the mI = −1/2 line, and (C) the mI = −1/2 line from a sample
containing 30% 17OH2. The five line multiplet at mI = −1/2 is consistent with
coordination of two nitrogens. Insensitivity to 15N placement at the first and third
glycines shows that these residues do not coordinate. Broadening by 17OH2 suggests
that water contributes to the coordination sphere. Spectra (3.5 GHz) were acquired in
D2O solution at 133 K.

Histidine residues may coordinate through both the imidazole as
well as the exocyclic backbone nitrogen. To test for this possibility in
component 2, the peptide me-HGXGW was investigated. (We note that
in addition to methylation, selectively 15N labeled histidine would also
be useful but is cost prohibitive.) Here, both the His backbone nitrogen
as well as the second Gly were methylated. With standard acetylation
of the N-terminus (see Materials and Methods), methylation at the His
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exocyclic nitrogen removes any possibility of its coordination to
copper. The observed X-band spectrum from a 1:1 complex of this
peptide with Cu2+ is distinct from spectra observed for component 1, 2,
or 3 binding (data not shown), thus demonstrating that His acts as a
bidentate ligand for copper in component 2 binding.
The results above suggest that component 2 arises from copper
coordination by both the His imidazole and its exocyclic nitrogen. As
noted above, oxygen atoms likely occupy the remaining equatorial
sites. To determine whether these oxygens are from solvent water
molecules, EPR experiments were performed on HGXGW in ∼30% 17O
water. The superhyperfine interaction of the 17O nucleus (I = 5/2),
when coordinated to copper, usually results in line broadening.57 At Xband, there was no appreciable difference in line shape. However, at
S-band, broadening of the mI = −1/2 line was clear as shown in Figure
5C, thus demonstrating the equatorial involvement of water.
Preliminary simulations were used to determine whether the
broadening was consistent with one or two water molecules, but the
results were inconclusive.
The investigations above show that in component 2 copper
binding, the octarepeat His provides two equatorial nitrogens with
water at one or both of the remaining equatorial sites resulting in 2N
2O coordination, as shown in Figure 6. His acts as a bidentate ligand
forming a six-membered ring with Cu2+ as found in crystal structures
of Cu−His complexes.58,59 This coordination mode is fully consistent
with the X- and S-band EPR, as well as the ESEEM studies on the
methylated and isotopically labeled peptides examined here.
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Figure 6 Models of the three equatorial coordination modes. For component 3, X may
represent either a fourth imidazole or a water molecule.

Because the proposed component 2 coordination mode (Figure
6) appears to take up all of the equatorial sites, Cu2+ should form a
1:1 complex with each octarepeat His. To test this directly, EPR
detected titrations were performed on HGXGWGQPHGXGW and
HGXGW using previously established methods.8,11 The longer peptide
with two putative binding segments takes up between 1.0 and 1.5
copper ions, and the pentamer binds as a 2:1 complex with copper. In
contrast to the expected 1:1 stoichiometry, these data suggest that
two HGGGW segments are required to stabilize component 2 binding.
To determine whether a neighboring His makes an additional contact
with Cu2+, we examined the His → Tyr substituted constructs
HGGGWGQPYGGGW and YGGGWGQPHGGGW, as well as an analogue
with three linked HGGGW segments, but with a His → Tyr mutation at
the second repeat (Table 1). Tyrosine was chosen because it is
approximately equivalent to His in size, is reasonably soluble, but lacks
a nitrogen capable of coordinating copper. Interestingly, all of these
constructs exhibit exclusively component 1 binding, as determined by
X-band EPR (data not shown).
The ESEEM spectra are consistent with a single equatorial
imidazole, and the five-line mI = −1/2 multiplet in the S-band spectra
indicates only two equatorial nitrogens. However, binding
stoichiometry and constructs with His → Tyr mutations suggest that
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two His residues in sequential repeat segments are required to
stabilize component 2. These data argue that a second imidazole may
coordinate but in an axial position. In square-pyramidal coordination
geometry, axial bonds to Cu2+ are often much longer and weaker than
equatorial due to the Jahn−Teller distortion. Although EPR spectra are
usually not sensitive to axial nitrogens, they may under some
circumstances be detectable by ESEEM arising from the directly bound
14
N.39 However, this signal is weak and typically not visible in the
presence of strong ESEEM signals from an equatorial imidazole.60 The
likelihood of this coordination mode and its structural implications will
be considered in the Discussion.
Component 3 Coordination − Low Cu2+ Occupancy.
Component 3 coordination is observed only in the constructs
KKRPKPWGQ(PHGGGWGQ)4, KKRPKPWGQ(PHGXGWGQ)4, and
(PHGGGWGQ)3 at low copper load (<1.0 equiv), and thus requires
three or four sequential HGGGW segments. Analysis of g∥ and A∥
suggests 3N 1O or 4N coordination (Table 2). In addition, reduction of
pH to 6.5, at a fixed Cu2+ concentration, leads to a relative loss of
component 1 binding but does not influence component 3 (data not
shown). The accumulation of these observations suggests that
component 3 arises from coordination of three or four neutral
imidazoles and is likely the dominant species previously observed at
reduced pH.8,25 In support of this assignment, Cu2+ in a 50-fold molar
excess of imidazole gives a spectrum that is nearly indistinguishable
from that of component 3 (data not shown), and the coupling terms g∥
and A∥ (Table 2) are close to those reported by Malmstrom and
Vanngard from Cu2+ with excess imidazole at pH 6.8.61
ESEEM is sensitive to multiple imidazole coordination as
reflected through combination peaks and an enhanced ΔmI = 2
signal.55 ESEEM spectra for PrP(23−28, 57−91) with 1.0 and 4.0 equiv
of Cu2+ are shown in Figure 7. The spectrum at 4.0 equiv (component
1) was previously assigned using 15N labeling and two-dimensional
hyperfine sublevel correlation spectroscopy (HYSCORE) and arises
from the His imidazole and the amide nitrogen of the third Gly in the
HGGGW segment.10 This spectrum shows no indication of combination
peaks, and the ΔmI = 2 signal at approximately 4.0 MHz is consistent
with a single imidazole. At 1.0 equiv, however, there are marked
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changes in the ESEEM spectrum (Figure 7). The lines arising from the
noncoordinated Gly(3) amide nitrogen are lost. Most notably, the ΔmI
= 2 signal is now prominent and, relative to the intense peak at 1.5
MHz, is increased in amplitude by a factor of 2−3 over that obtained
with 4.0 equiv of Cu2+. There are also weak signals at approximately
2.1, 2.4, and 3.1 MHz, consistent with combination peaks arising from
the fundamental low-frequency lines at exact cancellation. S-band EPR
was also obtained from PrP(23−28, 57−91) with 1.0 equiv of copper
and revealed a well-resolved seven- or nine-line multiplet for the mI =
−1/2 line (inset) consistent with coordination by three or four
equivalent nitrogens. Together, these data clearly suggest that
component 3 arises from multiple imidazole coordination.

Figure 7 Three-pulse ESEEM comparing PrP(23−28, 57−91) with 4.0 and 1.0 equiv of
Cu2+. At 4.0 equiv, component 1 dominates; the grid at the top shows the previously
determined assignment.10 At 1.0 equiv, which favors component 3, the enhanced ΔmI
= 2 feature at 4.1 MHz is consistent with multiple His coordination. The inset shows
the S-band mI = −1/2 line obtained with 1.0 equiv. The seven- or nine-line pattern
suggests 3N1O or 4N coordination by equivalent nitrogens.

To gain insight into the three-dimensional characteristics of the
distinct copper binding components, structural calculations were
performed using distance restraints arising from coordination sphere
appropriate for each of the binding modes. The polypeptide backbone
was left unrestrained, except where noted, thus resulting in significant
variations in backbone geometry for intervening loops. The results are
shown in Figure 8. Component 3 was calculated with coordination from
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the three N-terminal, octarepeat His imidazoles (His60, His68, His76),
with the fourth octarepeat His (residue 84) left free. The resulting
structure reveals an extensive segment of disordered polypeptide of
approximately 40 amino acids between the last His of the copper
binding segment (in this three His coordination structure) and the first
β-strand of the globular domain. Component 2 was developed using
the equatorial coordination mode shown in Figure 6 and an additional
long copper bond (2.4 Å) to the adjacent His imidazole in the following
octapeptide segment. The structure gives rise to two rather large
loops, each closed by copper coordination. Component 1 was
developed using the known restraints from the crystal structure of
Cu2+-HGGGW. In addition to extensive copper contacts to the His, Gly,
and Trp residues, two copper ions in adjacent repeats were brought
into close proximity of approximately 4.0 Å based on the observed
dipolar couplings.

Figure 8 Models of PrPC containing Cu2+ in the three coordination modes. The figure
at upper left shows PrP(60−231) bound to a single Cu2+ with component 3
coordination. To the upper right, the copper binding octarepeat domain is expanded.
In this mode, an additional His imidazole may also participate in copper binding. For
components 1 and 2, only the octarepeat domains are shown.

Discussion
The octarepeat domain of PrP, at pH 7.4, passes through a
series of distinct binding modes as a function of Cu2+ concentration.
The equatorial features are summarized in Figure 6, and
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representative N-terminal structures are shown in Figure 8. At low
occupancy, less than 1 equiv of Cu2+, three or four His imidazoles from
adjacent octarepeat segments contribute to the coordination sphere
(component 3 binding). This binding mode persists at a reduced pH of
6.5. Between 1 and 2 equiv, individual histidines provide the equatorial
environment, binding through the imidazole and the deprotonated
exocyclic nitrogen. The overall charge at the component 2 center is +1
resulting from the +2 charge of the copper and the −1 charge of the
histidine backbone amide nitrogen. Water molecules also contribute to
the coordination sphere. A second imidazole is also implicated in
component 2 binding; however, this interaction is not reflected by
ESEEM studies. Finally, from 2 to 4 equiv, where the octarepeat
domain saturates with Cu2+, component 1 coordination dominates.
This mode, described previously by both EPR and X-ray
crystallography,10 yields a neutral copper center because the charge on
the metal ion is offset by the two negative charges from the sequential
deprotonated glycine amides. Dipolar couplings and half field EPR
signals indicate that component 1 is accompanied by a significant
population of copper centers in near proximity, separated by 3.5−6 Å.
The data presented herein, along with previous studies, provide
a clear picture of both component 1 and component 3 binding.
Component 2, however, remains enigmatic. EPR spectra obtained from
various peptide constructs suggest that two adjacent octarepeats are
required to stabilize component 2. Substitution of His with Tyr in either
of the adjacent octapeptide repeats eliminates the component 2 signal.
Although these data suggest that two imidazoles coordinate to a single
Cu2+ center, this is not supported by ESEEM, which gives the
characteristic signal of a single equatorial imidazole. To reconcile these
findings, we consider two possibilities. First, the peptide conformation
may control the component 1/component 2 equilibrium. As noted, two
adjacent octarepeats are sufficient for both binding modes, with
component 1 dominating at full occupancy (2 equiv − one copper per
octarepeat). At half occupancy, with a single Cu2+ or less, the peptide
may be structured in a fashion that competes against normal
component 1 binding. For example, in interleukin-6, nuclear magnetic
resonance (NMR) shows that the side chains pairs Trp and His interact,
thus stabilizing secondary structure.62 Considering only two adjacent
octarepeats, it is noted that the segment WGQPH separates the glycine
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triplets. Perhaps an interaction between Trp and His stabilizes a βturn. Without the Trp indole available for component 1 coordination,
the copper may be driven instead to the remaining N-terminal His in a
component 2 binding fashion. Recent NMR experiments on
HGGGWGQP and (HGGGQGQP)3 in the absence of copper indeed do
find evidence of turns involving Trp.63 However, these studies also find
that the HGGGW segment adopts a conformation similar to that
involved in component 1 binding. In contrast to peptide conformation
competing with component 1 binding, it appears that the octarepeat
domain actually preorganizes to stabilize this binding mode.
A second possible role for the additional His in component 2
binding is direct imidazole coordination but through a longer and
weaker copper−nitrogen bond. Here, two recent crystallographic
studies are instructive. The complex Cu(His)2 is relevant both as a
source of exchangeable Cu2+ in blood and also as a means of
delivering therapeutic levels of copper in Menkes disease.64 One might
expect this complex to organize in a symmetric fashion with both
histidines contributing equally to the coordination environment.
Indeed, the complex Cu(d-His)(l-His) forms a structure in which each
His coordinates through an imidazole nitrogen and amino nitrogen,58
very much like component 2. Just recently, the Cu(l-His)2 structure
was determined and, surprisingly, revealed crystallographically distinct
histidine coordination.59 In the equatorial plane, one His bound
through its imidazole and amino nitrogens, whereas the other His
bound through its amino nitrogen and carboxylate oxygen. An
equivalent coordination mode had been previously determined from
ESEEM investigations on copper-doped single crystals of l-histidine.65
From a structural perspective, these studies may suggest that when an
l-His coordinates through its two nitrogens, steric constraints may
interfere with coordination of a second equatorial imidazole (although
we do note that a recent high field electron nuclear double resonance
(ENDOR) study did identify a symmetric bis-His copper complex with
each His contributing amino and imidazole nitrogens66). An unusual
bis-His complex was recently elucidated in a mutant of nitrite
reductase.67 In the wild-type protein, the type 2 Cu2+ center involves
three imidazoles. Removal of one of the imidazole groups in an H/V
mutant results in a bis-His complex with a water molecule contributing
to the coordination environment. Interestingly, the imidazoles are
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inequivalent with respect to the copper−nitrogen bond length. One
bond is approximately 2.0 Å, whereas the other is approximately 2.4
Å. The shorter bond length is typical of equatorial coordination,
whereas the longer bond is reminiscent of axial coordination in Cu2+
centers. As noted in the Results section, ESEEM of longer axial bonds
is extremely weak and difficult to observe in the presence of equatorial
imidazole coordination.60 In light of these findings, we propose that
component 2 likely involves two imidazoles at the copper center but
with one in an axial position that is relatively ESEEM silent.
Our studies presented here link well with several recent
investigations into PrP-copper binding. Valensin et al. reported detailed
potentiometric titrations on (PHGGGWGQ)2 and (PHGGGWGQ)4.34 At
fixed copper/peptide ratios, pH is scanned while monitoring proton
release. Remarkably, these investigations reveal a wide range of
distinct deprotonated species. Focusing on their data obtained with 1.0
equiv of copper interacting with (PHGGGWGQ)4 at pH 7.4, they find
evidence for a dominant species that has retained its backbone
protons, consistent with component 3. With 4.0 copper equiv, the
principle species just above pH 7.0 has given up nine protons. Our
component 1 binding mode (Figure 6) requires a loss of two protons
per bound Cu2+, which is quite close to that identified by Valensin et al.
They did not examine (PHGGGWGQ)4 with 2.0 equiv of Cu2+. However,
just above pH 6.0, they do find a species that has given up one proton
for each bound copper, consistent with component 2. In this same
study, NMR results obtained from (PHGGGWGQ)2 with trace amounts
of added Cu2+ show line broadening consistent with multiple His
coordination, again consistent with the component 3 structure.
Morante et al. used extended X-ray absorption spectroscopy
(XAS), both XANES and EXAFS, to probe copper binding in partially
and fully occupied octarepeat constructs, as well as in bovine rPrP.33 At
full occupancy, their analysis supported our reported crystal structure
with single imidazole coordination. However, at partial occupancy,
additional spectral features were identified consistent with two
coordinated imidazoles. These results held for octarepeat peptides as
well as full-length rPrP. On the basis of fluorescence titrations, Jackson
et al. suggested that the full PrP octarepeat domain binds only a single
Cu2+ with high affinity.15 Although the reported affinities from this
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study have been questioned,32 their modeling studies nevertheless
revealed low energy conformations with four-imidazole coordination.
Together, these disparate studies clearly point to diverse binding
modes, as directly observed here.
With regard to component 1 binding, our studies reveal dipolar
couplings arising from proximal copper centers. The dipolar signal
grows in concomitantly with component 1 formation and, therefore,
most likely arises from packing interactions between the structured
Cu2+-HGGGW segments. As noted in the Results section, analysis of
the dipolar splitting versus the half field signal intensity yields different
distance measurements, most likely indicating a range of
copper−copper distances. Direct interpretation of these data is difficult
because the observed distance-dependent signals may arise from the
interaction of more than two copper centers. Nevertheless, the short
3.0−6.0 Å distance range (Results) suggests that the individual
component 1 segments come into van der Waals contact. (Note that
the axial bond to water is approximately 2.4 Å so that stacking of the
ordered Cu2+-HGGGW segments would place the copper centers
approximately 3.0 Å apart.) Individual component 1 sites are
uncharged, as are the intervening GQP linker segments. Consequently,
upon full copper occupancy, the coupling data observed here suggest
that the octarepeat domain undergoes a partial hydrophobic collapse.
Such a collapse, similar to the principle force of protein folding, may
be mechanistically important. Using circular dichroism (CD) and
binding competition studies, Garnett and Viles found that the
octarepeat domain binds copper with strong positive cooperativity,
accompanied by structural organization of the GQP linker (Table 1)
between Cu2+-HGGGW segments.32 However, cooperative binding was
not observed for constructs containing only one or two octarepeats. It
was argued that at full copper occupancy, the octarepeat domain takes
on structure. Our results are consistent with this proposal and suggest
a physical driving force underlying structural reorganization upon full
copper occupancy.
The function of PrPC remains unknown. PrPC is internalized by
endocytosis at high copper concentrations, suggesting that PrP may
function as a copper sensor or transporter.27 The significant structural
changes associated with the transition from component 3 to
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component 1 binding (Figure 8) may serve to transduce the signal for
this internalization process. Although copper-induced endocytosis is
well established, it is not yet clear how this process links to any
specific PrPC function.28,68 Nevertheless, the emerging consensus is
that PrPC plays a neuroprotective role.69 Several mechanisms of action
have been proposed including cell signaling, suppression of apoptosis,
and antioxidant activity.69 With regard to antioxidant function, it has
been argued that PrPC is an enzyme − a neuronal superoxide
dismutase (SOD).70,71 However, the relatively weak micromolar affinity
observed for Cu2+ association with PrP is not characteristic of known
SODs.31,32 In addition, assays aimed at evaluating SOD function in
brain tissue as a function of PrP expression failed to find enhanced
activity.68,72 Here, we show that the octarepeat domain takes on widely
varying structures as a function of copper load. This is also
uncharacteristic of known SODs and, in accord, argues against such
function.
With regard to a neuroprotective role, several lines of
investigation do suggest an intimate relationship between PrP and
localized copper concentrations. Within the central nervous system,
PrPC is concentrated at presynaptic membranes.4 There is significant
copper efflux into the synapse as a function of both exocytosis and
neuronal depolarization.73-75 The peak synaptic concentration is not
certain, but estimates place [Cu2+] within the range from 3.0 μM74 to
250 μM.75 It appears that copper efflux is an obligatory component of
vesicle fusion leading to the release of neurotransmitter.5 Yet,
experiments using cell culture demonstrate that copper concentrations
in excess of 10 μM are toxic to neurons.76 Of significance here, PrP is
able to ameliorate this toxic effect − the protein binds Cu2+ at the
plasma membrane,28 and wild-type cells are more resistant to coppermediated oxidative stress as compared to PrP knockouts.28,76
Recent work with the doppel protein also supports a
neuroprotective role for PrP. The doppel protein is structurally
homologous to the globular C-terminus of PrP but lacks the PrP Nterminal octarepeat domain.77 Doppel protein (Dpl) is normally
expressed in the testis.77 However, work with transgenic mice has
shown that expression of Dpl in the central nervous system leads to
apoptosis and ataxia; this effect is offset by coexpression with PrP.
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Interestingly, recent mutagenesis experiments have shown that PrP's
ability to protect against Dpl toxicity requires the octarepeat domain.78
Given that PrPC takes up 4 equiv of Cu2+ in the octarepeat
domain, and that this domain is key for neuroprotection, points toward
a different type of antioxidant function. Component 1 binding stabilizes
copper in the Cu2+ oxidation state, thus reducing potential coppermediated redox chemistry.9 Thus, instead of acting as a redox enzyme,
PrPC may actually function as a copper buffer that sequesters the ion in
a relatively redox inactive form.5,17 In this scenario, the antioxidant
character arises from protection against deleterious copper-mediated
oxidation chemistry. Our structural studies here show that component
1 is dominant at high copper occupancy and thus maximizes PrPC's
antioxidant character with increasing Cu2+ concentrations.
The studies here provide structural details on the fundamental
copper binding modes at pH 7.4. However, it is currently unknown
which of the three modes are dominant in vivo. Moreover, it is not
clear how the globular C-terminal domain, or its mutants, influences
the equilibrium among these copper binding states. Elucidation of
these issues is sure to provide important new insights into PrPC
function and how the formation of PrPSc contributes to loss of this
function.
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